Regarding testicular tumour, the following are false except
The question is asking which statement is true (the exception) regarding testicular tumors. Since the options aren't provided, I'll have to assume common false statements and identify the correct one. Let me recall key facts about testicular tumors.
Core concept: Testicular tumors are classified into seminomas and non-seminomas. Seminomas are more sensitive to radiation. Non-seminomas include teratomas, embryonal carcinomas, yolk sac tumors. AFP is a tumor marker for non-seminomas, while hCG is for both. The peak incidence is in young adults, 15-35 years. Treatment for early stages is orchiectomy, followed by surveillance or adjuvant therapy.
Now, let's think of common false statements. For example, a false statement might be that seminomas are more common than non-seminomas (actually, non-seminomas are more common). Or that radiation is the first-line treatment for non-seminomas (they are usually treated with chemotherapy). Another false statement could be that testicular tumors are more common in older men, but they peak in young adults. Also, maybe a statement about the role of certain markers—like saying hCG is specific to seminomas, but it's actually present in both.
Assuming the correct answer is something like "Testicular tumors are radiosensitive" (which applies to seminomas), but wait, non-seminomas aren't radiosensitive. So a correct statement would be that seminomas are radiosensitive. If an option states that seminomas are radiosensitive, that's true. Alternatively, if an option says that testicular tumors are the most common cancer in males aged 15-44, that's true.
Let me structure the answer. The correct answer is likely about the radiosensitivity of seminomas. The false options might include things like non-seminomas being radiosensitive, or incorrect markers. Each wrong option would be explained as to why it's false.
Clinical pearl: Remember the markers—AFP for non-seminomas, hCG for both, and lactate dehydrogenase (LDH) for both. Seminomas produce hCG and LDH but not AFP. Non-seminomas produce AFP, hCG, and LDH.
Putting it all together, the correct answer is the one that correctly identifies a true statement about testicular tumors, such as their radiosensitivity, correct markers, or treatment approaches.
**Core Concept**
Testicular tumors are primarily classified as seminomas (radiosensitive) and non-seminomas (e.g., teratoma, embryonal carcinoma). Seminomas are the most radiosensitive tumors in clinical oncology, while non-seminomas require chemotherapy. Key tumor markers include AFP (non-seminoma), hCG (both), and LDH (both).
**Why the Correct Answer is Right**
If the correct answer states that **seminomas are radiosensitive**, this is accurate because seminomas exhibit extreme radiosensitivity due to their high proliferation rate and radiosensitivity of their cellular architecture. This property makes radiation therapy a cornerstone in early-stage seminoma management, with